Indiana will receive $1.1 million in a settlement with Pfizer Incorporated over its marketing of the drugs Zyvox and Lyrica.
Indiana Attorney General Greg Zoeller said Wednesday that the $1.1 million is Indiana's share of a $42.9 million settlement Pfizer reached to resolve allegations that the company unlawfully promoted those drugs.
Thirty-two states and the District of Columbia claimed that Pfizer used deceptive practices in marketing Zyvox, an antibacterial agent, and promoted off-label uses for Lyrica, which is used to treat fibromyalgia.
Under the settlement, Pfizer is not admitting wrongdoing but says it will reform how it markets the drugs.
(Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)